These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9685821)

  • 1. Iodixanol is readily eliminated by hemodialysis.
    Berg KJ; Rolfsen B; Stake G
    Acta Radiol; 1998 Jul; 39(4):372-4. PubMed ID: 9685821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis clearance of iosimenol, a novel iso-osmolar radiographic contrast medium.
    Hirao Y; Kashiyama E; Umehara K; Kohno M; Ikei N; Hogstrom B
    Acta Radiol; 2014 Oct; 55(8):938-44. PubMed ID: 24123996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Plasma Proteins on the Transport and Surface Characteristics of Polysulfone/Polyethersulfone and Asymmetric Cellulose Triacetate High Flux Dialyzers.
    Kim TR; Hadidi M; Motevalian SP; Sunohara T; Zydney AL
    Artif Organs; 2018 Nov; 42(11):1070-1077. PubMed ID: 29774568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
    de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
    Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of dialysis procedure, membrane surface and membrane material on iopromide elimination in patients with reduced kidney function.
    Matzkies FK; Reinecke H; Tombach B; Kosch M; Hegger K; Milius M; Hohage H; Kisters K; Kerber S; Schaefer RM
    Am J Nephrol; 2000; 20(4):300-4. PubMed ID: 10970983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of plasma insulin and C-peptide levels with 3 different high-flux dialyzers in diabetic patients on hemodialysis.
    Abe M; Okada K; Maruyama T; Inoshita A; Ikeda K; Uto E; Kikuchi F; Matsumoto K
    Int J Artif Organs; 2008 Oct; 31(10):898-904. PubMed ID: 19009508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing residual renal function and efficiency of hemodialysis--an application for urographic contrast media.
    Sterner G; Frennby B; Månsson S; Ohlsson A; Prütz KG; Almén T
    Nephron; 2000 Aug; 85(4):324-33. PubMed ID: 10940743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranitidine clearance during hemodialysis with high-flux membrane: comparison of polysulfone and cellulose acetate hemodialyzers.
    Tsuruoka S; Sugimoto KI; Hayasaka T; Saito T; Fujimura A
    Eur J Clin Pharmacol; 2000 Nov; 56(8):581-3. PubMed ID: 11151748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permeability of contrast media through hemodialysis membrane.
    Furukawa T; Ueda J; Higashino K; Takahashi S; Sakaguchi K; Imai T
    Acta Radiol; 1997 Sep; 38(5):918-21. PubMed ID: 9332256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo.
    Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E
    Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport Characteristics of Asymmetric Cellulose Triacetate Hemodialysis Membranes.
    Kim TR; Hadidi M; Motevalian SP; Sunohara T; Zydney AL
    Blood Purif; 2018; 45(1-3):46-52. PubMed ID: 29161718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced iopromide elimination in hemodialysis with cuprophan membranes.
    Matzkies FK; Reinecke H; Tombach B; Koeneke J; Hohage H; Kisters K; Schaefer RM
    Acta Radiol; 2000 Nov; 41(6):671-3. PubMed ID: 11092496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The past, present and future of the dialyzer.
    Mineshima M
    Contrib Nephrol; 2015; 185():8-14. PubMed ID: 26023010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of plasma porphyrins with high-flux hemodialysis in porphyria cutanea tarda associated with end-stage renal disease.
    Carson RW; Dunnigan EJ; DuBose TD; Goeger DE; Anderson KE
    J Am Soc Nephrol; 1992 Mar; 2(9):1445-50. PubMed ID: 1627767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ofloxacin clearance during hemodialysis: a comparison of polysulfone and cellulose acetate hemodialyzers.
    Thalhammer F; Kletzmayr J; El Menyawi I; Kovarik J; Rosenkranz AR; Traunmüller F; Hörl WH; Burgmann H
    Am J Kidney Dis; 1998 Oct; 32(4):642-5. PubMed ID: 9774127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes.
    DeSoi CA; Sahm DF; Umans JG
    Am J Kidney Dis; 1992 Oct; 20(4):354-60. PubMed ID: 1415203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial.
    Kerr PG; Sutherland WH; de Jong S; Vaithalingham I; Williams SM; Walker RJ
    Am J Kidney Dis; 2007 Apr; 49(4):533-9. PubMed ID: 17386321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hollow fiber shape alters solute clearances in high flux hemodialyzers.
    Leypoldt JK; Cheung AK; Chirananthavat T; Gilson JF; Kamerath CD; Deeter RB
    ASAIO J; 2003; 49(1):81-7. PubMed ID: 12558312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on middle molecule removal in low-flux polysulfone dialyzers: impact of flows and surface area on whole-body and dialyzer clearances.
    Polaschegg HD
    Hemodial Int; 2006 Apr; 10(2):215-6; author reply 216. PubMed ID: 16623678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.